Cases & Deals

Idenix asserts patent infringement against Gilead in Australia related to Sovaldi® and Harvoni®

Clients Idenix Pharmaceuticals LLC

Jones Day represents Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in patent litigation against Gilead in the Federal Court of Australia over sofosbuvir, the active ingredient in Sovaldi® and Harvoni®, Gilead's blockbuster drugs for treating Hepatitis C. Subject matter is nucleoside analogs and prodrugs for treating Flaviviridae infections, including HCV.

Gilead Sciences Pty Ltd v. Idenix Pharmaceuticals Inc & Ors, No NSD 48/2013 (Federal Court of Australia, January 17, 2013)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.